Acrivon Therapeutics, Inc. (ACRV) has 20 open-market insider trades by 13 insiders since 2022. Over the last six months insiders net sold $40K. The most active filer is Peter Blume-Jensen, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| RA Capital Healthcare Fund LP | Dir10% Owner | — | 1 | $42.4M | 2024-04-11 |
| Perceptive LIFE Sciences Master FUND Ltd. via Joseph Edelman | 10% Owner | — | 1 | $20.0M | 2024-04-11 |
| Perceptive Advisors LLC | 10% Owner | — | 2 | $7.2M | 2025-05-01 |
| Andreas Hadjimichael | 10% Owner | — | 1 | $5.0M | 2022-11-17 |
| Peter Blume-Jensen | CEOPres | — | 3 | $117K | 2026-08-25 |
| Chione Ltd | 10% | — | 1 | $72K | 2023-06-14 |
| Anastasis Nikolaou | 10% | — | 1 | $25K | 2023-06-15 |
| Eric Devroe | COO | — | 2 | $18K | 2026-08-18 |
| Adam D. Levy | CFO | — | 2 | $17K | 2026-08-04 |
| Mary Miller | CLO | — | 3 | $2K | 2026-10-05 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Mary Miller | CLO | Sell | $585 | 2026-10-05 |
| Peter Blume-Jensen | CEO & President | Sell | $31K | 2026-08-25 |
| Eric Devroe | COO | Sell | $1K | 2026-08-18 |
| Katharine Peterson | CAO | Sell | $203 | 2026-08-18 |
| Mary Miller | CLO | Sell | $372 | 2026-08-18 |
| Peter Blume-Jensen | CEO & President | Sell | $3K | 2026-08-18 |
Companies that share insiders with ACRV, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Erick Gamelin | — | Sell | $804 | 2026-08-18 |
| Adam D. Levy | CFO | Sell | $2K | 2026-08-04 |
| Mary Miller | CLO | Sell | $1K | 2026-07-21 |
| Adam D. Levy | CFO | Buy | $15K | 2026-01-14 |
| Peter Blume-Jensen | President | Buy | $82K | 2026-01-14 |
| Eric Devroe | COO | Buy | $17K | 2026-01-13 |
| Perceptive Advisors LLC | 10% Owner | Sell | $2.0M | 2025-04-30 |
| Perceptive Advisors LLC | 10% Owner | Sell | $5.1M | 2025-04-25 |
| Perceptive LIFE Sciences Master FUND Ltd. | 10% Owner | Buy | $20.0M | 2024-04-11 |